Author Question: Which of the following contribute to lack of clarity in assessment reports? a. excessive length ... (Read 72 times)

HudsonKB16

  • Hero Member
  • *****
  • Posts: 535
Which of the following contribute to lack of clarity in assessment reports?
 
  a. excessive length
  b. over reliance on technical information and statistics
  c. excessive brevity
  d. all of the above

Question 2

A formalized indication of a desire to not receive life-sustaining medical treatment if one becomes incapacitated is called
 
  a. a living will.
  b. an advance medical directive.
  c. civil competency.
  d. all of the above



sarajane1989

  • Sr. Member
  • ****
  • Posts: 296
Answer to Question 1

d

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library